AGP Picks
View all

AGP Executive Report

Last update: 5 hours ago

Abortion Rights in Liechtenstein: The parliament narrowly backed a bill to legalise elective abortion in the first 12 weeks, but Hereditary Prince Alois has pledged to veto it—meaning the current ban (with limited exceptions) is likely to stay, and many people will continue to seek care abroad. Animal Health Alert: France is reporting rapid spread of “European Shamonda” among dairy cattle, with warnings that it can be especially risky for pregnant animals, including miscarriage or birth defects—an issue that has already appeared across parts of Europe including Liechtenstein. Cross-Border Health Policy: German-speaking health ministers met in Luxembourg to push cooperation on workplace prevention, pension system modernisation, and tackling neurodegenerative diseases—topics that directly affect long-term wellbeing across the region. Workforce & Training: A UK policy shift prioritising home-trained medical graduates for NHS specialty training is sharply reducing the share of “non-priority” doctors taking places, a sign of how training rules can reshape healthcare staffing. Reflux Treatment Business: Implantica announced a Capital Markets Day in Stockholm focused on its RefluxStop® launch strategy in the U.S., tied to a large acid reflux patient market.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Sep. 7, 2026

Swiss parabolic flight campaign pivots toward commercial space applications

AGP

fallback image
Jul. 3, 2026

European Commission authorizes CinnaGen’s osteoporosis biosimilar Zandoriah in EU

AGP

fallback image
Jul. 28, 2026

The European releases its Summer 2026 edition

AGP

fallback image
Jul. 2, 2026

American Swiss Foundation honors Adrian Keller at leadership dinner in Rüschlikon

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Liechtenstein parliament backs abortion legalization, but Prince vows veto

Liechtenstein parliament backs abortion legalization, but Prince vows veto

Focus on modernising pension systems: German-speaking health ministers meet in Luxembourg

Focus on modernising pension systems: German-speaking health ministers meet in Luxembourg

Liechtenstein parliament backs abortion law but prince can veto it

Liechtenstein parliament backs abortion law but prince can veto it

Your Weekly Recap: Luxembourg pupils return to school amid PISA concerns, young politicians rally to safeguard democracy, and UK, France, and Canada halt Israeli settlement imports

Your Weekly Recap: Luxembourg pupils return to school amid PISA concerns, young politicians rally to safeguard democracy, and UK, France, and Canada halt Israeli settlement imports


fallback image
Jul. 23, 2026

Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing

GlobeNewswire, Inc.

fallback image
Jul. 24, 2026

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

GlobeNewswire, Inc.

fallback image
Sep. 7, 2026

A European Gateway to Commercial Space is established in Dübendorf

EIN Presswire

fallback image
Jul. 1, 2026

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

GlobeNewswire, Inc.

fallback image
Sep. 7, 2026

8th Swiss Parabolic Flight Campaign: A Clear Shift Toward Commercial Space

EIN Presswire

fallback image
May 19, 2026

SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Tighter EU Investment Conditions Targeted at China Are 'Fair', Says Expert
Play
Tighter EU Investment Conditions Targeted at China Are 'Fair', Says Expert
YouTube video thumbnail: Finland Completes Work on 200km Fence Along Border With Russia
Play
Finland Completes Work on 200km Fence Along Border With Russia
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Did the EU Block the New Siri AI, or Is Apple to Blame?
Play
Did the EU Block the New Siri AI, or Is Apple to Blame?
YouTube video thumbnail: Trump Says “The Moon Is Ours” as Europe Debates Its Future in Space
Play
Trump Says “The Moon Is Ours” as Europe Debates Its Future in Space

Video Title

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.